Pliant Therapeutics PLRX
NASDAQ PLRX
$0.91 +0.01 (+1.52%)
At close: Oct 20, 2026 · 4:00 PM EDT

Pliant Therapeutics (PLRX) Non-Current Debt (2022 - 2024)

Updated

Analysis

Pliant Therapeutics (PLRX) Non-Current Debt (2022 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 37.34 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 62.48 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 23.68 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 23.83 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 60.50 Bn
10 Pliant Therapeutics 56.49 Mn -705.25 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 1,000.00
Mar 31, 2024 19.91 Mn
Dec 31, 2022 -150,000.00
API Access

Pliant Therapeutics Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=PLRX&period=max&api_key=YOUR_API_KEY